Last reviewed 01/2018
This is licensed for the prevention and treatment of postmenopausal osteoporosis.
It is also licensed for the prevention and treatment of steroid induced osteoporosis.
The summary of Product Characteristics must be consulted before prescribing this drug.
unwanted effects and precautions
bisphosphonates in the treatment of osteoporosis